|
SAR1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57659996169457E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83210002724365E-10 |
| Normal-vs-Stage2 |
1.403020E-03 |
| Normal-vs-Stage3 |
2.263500E-02 |
| Normal-vs-Stage4 |
1.975980E-01 |
| Stage1-vs-Stage2 |
7.018400E-01 |
| Stage1-vs-Stage3 |
1.850020E-01 |
| Stage1-vs-Stage4 |
3.329200E-01 |
| Stage2-vs-Stage3 |
5.343000E-01 |
| Stage2-vs-Stage4 |
5.660600E-01 |
| Stage3-vs-Stage4 |
9.451800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47900003355517E-09 |
| Normal-vs-AfricanAmerican |
5.58649999999883E-05 |
| Normal-vs-Asian |
3.268600E-01 |
| Caucasian-vs-AfricanAmerican |
4.980600E-01 |
| Caucasian-vs-Asian |
6.073800E-01 |
| AfricanAmerican-vs-Asian |
7.765600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64890323617328E-11 |
| Normal-vs-Female |
2.483900E-02 |
| Male-vs-Female |
2.716800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.90240000003317E-06 |
| Normal-vs-Extreme_Weight |
1.59320001635876E-09 |
| Normal-vs-Obese |
2.379700E-04 |
| Normal-vs-Extreme_Obese |
1.311830E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.073200E-01 |
| Normal_Weight-vs-Obese |
1.360650E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.250000E-01 |
| Extreme_Weight-vs-Obese |
1.019210E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.928000E-01 |
| Obese-vs-Extreme_Obese |
3.099600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.571400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.92195999999534E-05 |
| Normal-vs-Age(61-80Yrs) |
5.70880009931329E-11 |
| Normal-vs-Age(81-100Yrs) |
3.445300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.003600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.335890E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.026460E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.509900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.593900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.505400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.90210002882463E-09 |
| Normal-VS-Type2 PRCC |
1.90309989989146E-11 |
| Normal-VS-KIRP CIMP |
4.587600E-01 |
| Normal-VS-Unclassified PRCC |
1.268390E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.956600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.083330E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.140400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.50090000000348E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
1.802100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.470500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.39379999050971E-09 |
| Normal-vs-N1 |
6.966300E-02 |
| Normal-vs-N2 |
9.468800E-01 |
| N0-vs-N1 |
2.994500E-02 |
| N0-vs-N2 |
4.130600E-01 |
| N1-vs-N2 |
5.667800E-01 |
|
|
